lifestyle.pluralist.com

MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity

MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity – NEWSnet – News… as it used to be

More Press Releases

April 30, 2026

The Best Book Company Unveils the Author Project Roadmap for Assistance with Writing and Publishing

April 30, 2026

Big One Publisher Announces Updated Framework for eBook Self Publishing, Ghostwriting, and Book Marketing Services

April 30, 2026

Scientology Communities Across Europe Highlight Civic Responsibility and EU Values

April 30, 2026

Hacksaw Announces Change Of Group CEO